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Mycobacterium tuberculosis is a highly efficient pathogen, killing millions of infected people annually. The
capacity of M. tuberculosis to survive and cause disease is strongly correlated to their ability to escape
immune defense mechanisms. In particular, M. tuberculosis has the remarkable capacity to survive within
the hostile environment of the macrophage. Understanding M. tuberculosis virulence strategies will not
only define novel targets for drug development but will also help to uncover previously unknown signaling
pathways related to the host’s response to M. tuberculosis infection.Introduction
Mycobacterium tuberculosis is a global health threat, infecting
about one third of the human population and resulting in an an-
nual casualty of 2 million people worldwide (Dye et al., 1999;
Yew and Leung, 2008). While antimycobacterial therapy exists,
currently available drugs are only partially effective because of
the impermeable nature of the mycobacterial cell wall and the
propensity of M. tuberculosis to develop resistance (Warner
and Mizrahi, 2006). One additional problem is thatM. tuberculo-
sis has the capacity to remain viable within infected hosts for
a prolonged time.
Infection of a host withM. tuberculosis is initiated following the
inhalation of droplets (aerosols) containing a small number of
bacilli (Kaufmann, 2001). Once in the lung, bacilli are internalized
through phagocytosis by the resident macrophages of the lung,
the alveolar macrophages (Figure 1). Alveolar macrophages ac-
tivated by the appropriate stimuli can effectively transfer the
phagocytosed M. tuberculosis to the destructive environment
of lysosomes, but some bacilli are able to escape lysosomal de-
livery and survive within the macrophage (Armstrong and Hart,
1975; Kaufmann, 2001; Russell, 2001). Infected macrophages
can then either remain in the lung or are disseminated to other
organs in the body. However, only a minority (10% of infected
people [World Health Organization, 2007]) develop tuberculosis,
because inmost healthy individuals, the immune defense system
is sufficient to keep M. tuberculosis in check such that disease
cannot develop (http://www.who.int/mediacentre/factsheets/
fs104/en/index.html).
The Default Route for Microbes
to Macrophage Lysosomes
Phagocytosis of M. tuberculosis by macrophages proceeds
through a series of membrane invagination, budding, and fusion
events, resulting in the formation of the phagosome (Aderem and
Underhill, 1999). Apart from its size (>0.5 mm), themembrane and
luminal composition in terms of lipids and proteins of the pha-
gosome is similar to that of endosomes, small vesicles utilized
by the cell to internalize fluids (that may includemicrobial derived
material) from the extracellular environment (Schmid, 1997).
Material internalized into phagosomes and endosomes can
further be distributed within the cell through a series of vesicletrafficking events (Gruenberg and Stenmark, 2004; Schmid,
1997) that may deliver this material to the antigen processing
and presentation pathway (Wolf and Ploegh, 1995; Pieters,
1997). This pathway consists of endosome-related compart-
ments that are dedicated for the degradation of antigens and
where antigenic fragments bind tomajor histocompatibility com-
plex (MHC) class II molecules. From theseMHCclass II compart-
ments, peptide-loaded MHC class II molecules are shuttled to
the plasma membrane where they function in the activation of
T cells in order to generate an adaptive immune response
against the microbe whose material has been digested and
presented (Amigorena et al., 1994; Tulp et al., 1994; West
et al., 1994). Besides peptide fragments, mycobacterial lipids
generated within endosomal/lysosomal organelles are also pre-
sented to gd T cells (De Libero and Mori, 2005) (Figure 2).
The final destination of both the phagosomal and endosomal
cargo is the lysosome, where extensive degradation of the cargo
can occur. This results in the clearance of potentially harmful
material from circulation through endocytosis and subsequent
destruction of pathogens. The reader is referred to several excel-
lent reviews dealing with the molecular processes that govern
the transfer of material between different intracellular organelles
(Mellman, 1996; Rothman andWieland, 1996; Schekman, 1994).
For this review, it is important to realize that both proteins as well
as (glyco)lipids play important roles in the regulation of vesicular
traffic (Haucke and Di Paolo, 2007). As will be described below,
pathogenic mycobacteria have evolved mechanisms to interfere
with both (glyco)lipid and protein-mediated mechanisms that
regulate the transfer of cargo to lysosomal organelles for
destruction.
Phagocytosis into the Macrophage—A Special Port of
Entry forM. tuberculosis to Ensure Intracellular Survival
The entry of M. tuberculosis into macrophages can occur via an
array of different receptor molecules, including complement re-
ceptors, mannose receptor, the dendritic cell-specific intercellu-
lar adhesionmolecule (ICAM)-3-grabbing nonintegrin (DC-SIGN),
and Fc receptors (Ernst, 1998; Cambi et al., 2005; Greenberg,
1999). The ability of multiple receptor molecules to internalize
M. tuberculosis is likely related to the complex structure of the
cell surface ofM. tuberculosis (Brennan and Nikaido, 1995). TheCell Host & Microbe 3, June 2008 ª2008 Elsevier Inc. 399
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impact on the survival chances of M. tuberculosis once inside
the macrophage. For example, ingestion of particles through
Fc receptors results in a respiratory burst and an inflammatory
response in macrophages; in contrast, internalization via CR3 re-
ceptors prevents the activation of the macrophages (Caron and
Hall, 1998). In addition, CR3-mediated uptake ofM. tuberculosis
is strictly dependent on the presence of host plasma membrane
cholesterol (Gatfield and Pieters, 2000; Peyron et al., 2000). The
presence of cholesterol at the mycobacterial phagosome is also
required for the prevention of phagosome-lysosome fusion (Gat-
field and Pieters, 2000; Jayachandran et al., 2007). Interestingly,
mycobacteria may utilize cholesterol to survive within chronically
infected macrophages (Pandey and Sassetti, 2008). Thus, inter-
nalization by certain receptors is clearly beneficial toM. tubercu-
losis andmechanismsmay exist for selectively binding and inter-
nalization by specific receptors, such as CR3, to help avoid
immediate and long-term degradation inside macrophages.
Establishment of a Balance: The Granuloma
In a majority of infected individuals, a certain number of macro-
phages exist that harbor viable mycobacteria, yet most infected
individuals do not develop disease. This raises the question of
how these bacilli are contained by the host immune system. M.
tuberculosis residing within macrophages is kept in check within
structures termed granulomas (Cosma et al., 2003; Flynn and
Chan, 2003). Although the precise biology of granulomas remain
only partially understood, it is believed that granulomas are
structured clusters containing M. tuberculosis infected macro-
Figure 1. Infection with M. tuberculosis: Establishment of
a Balance
M. tuberculosis is inhaled via aerosols into the lung, where they are
internalized within alveolar macrophages. Inside nonactivated macro-
phages (those within the center of the granuloma), mycobacteria (indi-
cated in red) resist destruction, although macrophage activation by T
cell-dependent cytokines can overcome this resistance (activated
macrophages are believed to reside at the periphery of the granu-
loma). In case of an immunodeficiency, for example when T cell func-
tion is compromised, unrestricted growth within macrophages causes
dissemination of tubercle bacilli. Modified with permission from
(Kaufmann, 2001).
phages in the center, surrounded by different types of
immune cells, in particular macrophages and T lympho-
cytes (Gordon et al., 1994) (Figure 1). Both nonactivated
and activated macrophages coexist within granulomas,
with the activated macrophages processing and present-
ing mycobacterial antigens to the surrounding T lympho-
cytes (Chan and Flynn, 2004). Following presentation of
mycobacterial antigens, the T cells become activated
through the triggering of T cell receptors (Kaufmann,
1993; Pieters, 1997). Activated T cells secrete cytokines
and chemokines keeping the macrophages in an acti-
vated state and ensuring the recruitment of other immune
cells to the site of infection. The precise status ofM. tuber-
culosis within granulomas is not clear. They may exist as
actively dividing bacilli or in a so-called ‘‘dormant’’ state.
Also, it cannot be excluded that both actively dividing
and dormant bacilli can occur within the same infected
individual depending on the stage of the disease (Dannenberg,
2003; Dheda et al., 2005; Karakousis et al., 2004). Regardless,
M. tuberculosis can persist for a long time, even up to the lifetime
of the host (Young et al., 2002), within these structures, and as
long as host immunity (in the form of activated macrophages
and functional T cells) is effective, there is usually no adverse ef-
fect of the M. tuberculosis on the host’s health (Saunders and
Britton, 2007). Thus, the granuloma structure likely represents
a balance between a potentially dangerous pathogen and the
host immune system. The delicacy of this balance is illustrated
by the observation that any deterioration of host immunity results
in a potentially life-threatening condition of an individual harbor-
ing live M. tuberculosis (Bartlett, 2007). How this balance of M.
tuberculosis maintenance within macrophages is achieved is
a critical issue in understanding M. tuberculosis pathogenesis.
The rest of this review will examine mechanisms that both mac-
rophages and M. tuberculosis utilize to maintain this balance.
Particular attention will be paid to how M. tuberculosis modu-
lates transport pathways within macrophages to block the deliv-
ery of M. tuberculosis to lysosomes, bactericidal activities of
activated macrophages, and how M. tuberculosis can prevent
the activation of macrophages.
Mycobacterial Prevention of Phagosome-Lysosome
Fusion
Mycobacterial Interference with Lipid-Mediated
Signaling Processes in Host Macrophages
M. tuberculosis is an unusual microbe with respect to its cell-wall
composition. In contrast to many other bacteria,M. tuberculosis400 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.
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moieties (Brennan and Nikaido, 1995). Loss of mycobacterial
cell wall components is typically correlated with reduced viru-
lence, suggesting that the pathogen’s cell wall is important for
mycobacterial survival inside the host cell (Glickman et al.,
2000; Makinoshima and Glickman, 2005).
M. tuberculosis glycolipids can interfere with phagosome-
lysosome fusion through blocking a normal host trafficking event
that is regulated by phosphatidylinositol 3-phosphate (PI3P).
PI3P is a host membrane component that is essential for phago-
lysosome biosynthesis (Roth, 2004). Locally generated by phos-
phatidylinositol 3-kinase (PI3 kinase) on early endosomal and
phagosomal membranes, PIP3 is believed to present a docking
site for several proteins involved in thematurationof phagosomes
into lysosomes, such as the hepatocyte growth factor-regulated
tyrosine kinase substrate (Hrs) and the early endosomal autoan-
tigen 1 (EEA1) (Birkeland and Stenmark, 2004; Itoh and Taken-
awa, 2002; Wurmser et al., 1999). Thus, while in uninfected cells,
the generation of PI3P regulates the delivery of phagocytosed
cargo to lysosomes,M. tuberculosis interfereswith this trafficking
event by actively preventing PI3P accumulation on phagosomal
membranes (Fratti et al., 2003). This is achieved via a 2-fold strat-
egy. First, M. tuberculosis interferes with the activity of the PI3
kinase hVP34, thereby preventing the generation of PI3P on the
phagosomal membrane and blocking phagosome-lysosome
fusion. This inhibitory activity was proposed to be mediated by
the mycobacterial cell-wall component lipoarabinomannan (LAM),
since the addition of purified LAM was sufficient to prevent lyso-
somal delivery (Vergne et al., 2003). However, since killed
mycobacteria fail to block lysosomal transfer yet possess LAM,
it remains unclear how LAM-mediated blockage of trafficking is
regulated. A second strategy relies on the prevention of PI3P
accumulation on phagosomes by the activity of a phosphatase,
termed SapM, a eukaryotic-like acid phosphatase secreted by
M. tuberculosis (Saleh and Belisle, 2000). SapM is presumably
released within the host cell cytosol upon infection, where it
may hydrolize PIP3 on phagosomal membranes (Vergne et al.,
2005). Apart from lipid phosphatases, M. tuberculosis also
possesses protein phosphatases (PtpA and B [Grundner et al.,
2005]) that interfere with host trafficking processes, possibly by
modulating vacuolar sorting proteins (Bach et al., 2008).
Interfering through theProduction of Host-like Signaling
Molecules: The Mycobacterial Eukaryotic-like
Protein Kinases
Typically, prokaryotes regulate their signal transduction through
two component systems (Stock et al., 2000), and until recently
a function for serine/threonine kinases in bacteriawasnot known.
However, when the genome ofM. tuberculosis was sequenced,
11members of the eukaryotic-like serine/threonine kinase family
were identified (Cole et al., 1998).Horizontal gene transfermaybe
a mechanism by which mycobacteria have acquired this set of
eukaryotic-like serine/threonine kinases, which are likely to be
involved in the modulation of signal transduction cascades
(Av-Gay and Everett, 2000; Nguyen and Pieters, 2005) .
Interestingly, most prokaryotic serine/threonine kinases as
well as the phosphatases appear to be modulators of develop-
mental changes or involved in the host-pathogen interaction
(Greenstein et al., 2005; Nguyen and Pieters, 2005). Indeed, of
the 11 kinases analyzed from M. tuberculosis, most appear tobe involved either in processes such as cell division and stress
responses, or, alternatively, in the modulation of host cell re-
sponses. Consistent with a function in the regulation of myco-
bacterial physiology, the majority of the mycobacterial kinases
are transmembrane molecules, displaying the kinase domain in
the bacterial cytosol. Only two of these kinases, PknG and
PknK, are soluble molecules, and of these, PknG is the only
soluble kinase maintained in the genome of all pathogenic
mycobacteria, including Mycobacterium leprae. This is impor-
tant, sinceM. leprae possesses only one-third of the genes pres-
ent in M. tuberculosis and has therefore been referred to as the
mycobacterial pathogen having theminimal set of genes needed
for pathogenicity (Cole et al., 2001).
Interestingly, PknG is only required for the survival ofM. tuber-
culosis once the bacteria have been internalized inside macro-
phage phagosomes and both wild-type and PknG-deficient
bacteria survive equally well in in vitro cultures (Nguyen et al.,
2005). In macrophages, PknG-deficient mycobacteria show an
attenuated phenotype, cannot resist lysosomal transfer, and
are rapidly degraded (Majlessi et al., 2007; Walburger et al.,
2004; Cowley et al., 2004). Whereas a PknG homolog present
in Corynebacteriium glutamicum was suggested to be involved
in glutaminemetabolism (Niebisch et al., 2006), a careful analysis
of mycobacteria lacking PknG revealed similar cell growth, glu-
tamine uptake processes, and intracellular glutamine concentra-
tions (Nguyen et al., 2005), arguing against a role for mycobacte-
rial PknG in the regulation of glutamine metabolism. As a soluble
molecule, PknG is released frommycobacteria inside themacro-
phage phagosomes and accesses the cytosol (Walburger et al.,
2004). The mechanism of cytosolic translocation of PknG and
the precise action of PknG on host trafficking machinery remains
largely unknown.
The kinase activity of PknG is essential for the prevention of
phagosome-lysosome fusion, since overexpression of a domi-
nant negative mutant form of PknG results in lysosomal delivery
of the bacteria (Walburger et al., 2004). As several factors that are
involved in the regulation of intracellular transport reactions
require phosphorylation (Morgan and Burgoyne, 2004; Turner
et al., 1999), it is likely that PknG acts by phosphorylating a
host molecule, thereby preventing the activity of this host factor
in carrying out phagosome-lysosome fusion.
The requirement of the PknG kinase for mycobacterial survival
inside macrophages has spurred the search for specific kinase
inhibitors, since kinases are attractive targets for the develop-
ment of inhibitory compounds (Huse and Kuriyan, 2002; Noble
et al., 2004). Most drugs currently used to treat tuberculosis
act to interfere directly with mycobacterial physiology. In con-
trast, blocking the activity of PknG may allow the macrophage
to carry out its innate antimicrobial activity, by redirecting
intracellularly residing mycobacteria from phagosomes to lyso-
somes, thereby inducing their destruction. An additional advan-
tage of targeting PknG may be that as a secreted molecule,
inhibitors do not need to acquire access to the extremely imper-
meable mycobacterial cell wall. Indeed, a highly selective inhib-
itor for PknG has been recently identified (Scherr et al., 2007).
Although PknG is highly homologous to eukaryotic serine/threo-
nine kinases, it possesses a unique domain not found in eukary-
otic kinases. The inhibitor interacts with this unique domain of
PknG, explaining its specificity (Scherr et al., 2007).Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc. 401
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The mycobacterial phagosome is formed upon entry of mycobacteria and remains accessible to the extracellular environment, e.g., for the acquisition of iron
through the transferrin receptor (TfR). Once inside phagosomesM. tuberculosis secretes the phosphatase SapM and the serine/threonine kinase PknG to prevent
phagosome-lysosome fusion. The mycobacterial phagosome (light-yellow circle) is also prevented from fusing with lysosomes by the active recruitment of the
host protein coronin 1/TACO (yellow). Lysosomal-associated membrane protein 1 (LAMP1) and vacuolar type H+-ATPase (V-ATPase) are components of the
lysosome. Furthermore, theM. tuberculosis proteasome neutralizes the effect of nitric oxide generatedwithinmacrophages. The Toll-like receptor (TLR) signaling
pathway can modulate phagosome-lysosomal fusion via the activation of p38MAPK, although it is unclear whether mycobacteria interfere with this pathway. In
addition, the antimicrobial peptide cathelicidin (also referred to as LL-37) is induced through TLR signaling via activation of the vitamin D receptor by 1,25-
dihydroxyvitamin D3 (1,25D3) converted from vitamin D3 (25D3) by 1-hydroxylase (CYP27B1) . See text for further details. Reprinted with permission from Pieters
(2008b).Interfering with Host Cell Signaling: Hijacking
the Calcineurin Pathway
The prolonged survival ofM. tuberculosiswithin their mammalian
host cells suggested that these pathogens, apart fromproducing
virulence factors such as SapM and PknG, have evolved mech-
anisms to utilize host molecules for their own survival. An analy-
sis of the protein composition of the mycobacterial phagosome
showed the exclusive presence of a protein that was strongly re-
tained on phagosomes harboring viable mycobacteria, but this
protein did not associate to any other subcellular organelle (Fer-
rari et al., 1999; Hasan et al., 1997). This protein, initially termed
TACO (for Tryptophan aspartate containing coat protein, also
known as P57), is now referred to as coronin 1 and is recruited
to phagosomes containing live bacilli, but rapidly released from
phagosomes containing killed mycobacteria, suggesting that
coronin 1 is an important host factor that specifically prevents
the lysosomal delivery and death of mycobacteria inside macro-
phages (Ferrari et al., 1999; Gatfield et al., 2005).
Coronin 1 is a member of the WD repeat-containing protein
family of coronins. The founding member of this protein family
was identified in the amoeba Dictyostelium discoideum and is
involved in the regulation of actin-based dynamics (de Hostos,402 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.1999). In mammalian cells, up to seven coronin isoforms can be
expressed, and based on the homology toDictyostelium coronin,
mammalian family members were thought to regulate the F-ac-
tin-dependent cytoskeleton (Uetrecht andBear, 2006). However,
no defects in the F-actin cytoskeleton or F-actin-mediated cellu-
lar processes is apparent in coronin 1-depleted macrophages
cell lines or in cells from coronin 1-deficient mice (Jayachandran
et al., 2007, 2008; Mueller et al., 2008). Instead of modulating the
actin cytoskeleton, coronin 1 prevents phagosome-lysosome
fusion by regulating calcium-dependent signaling processes.
When macrophages are infected with mycobacteria, they re-
spond with a sustained calcium flux that is dependent of the
presence of coronin 1. The coronin 1-dependent cytosolic influx
of calcium activates the calcium-dependent phosphatase cal-
cineurin. In the absence of coronin 1, influx of calcium does not
occur and therefore calcineurin is not activated. Strikingly, the
coronin 1-dependent activation of calcineurin is required for
blocking phagosome-lysosome fusion (Jayachandran et al.,
2007). Activated calcineurin links up to several downstream
signaling cascades, ranging from the transfer of transcription fac-
tors to the nucleus to dephosphorylation of proteins involved in
endocytosis (Cousin and Robinson, 2001; Winslow et al., 2003).
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phagosome and the precise activity of calcineurin required to
prevent lysosomal delivery of mycobacteria are unknown. How-
ever, mycobacterial proliferation inside macrophages is fully
blocked by the presence of the calcineurin blockers cyclosporin
A and FK506, further providing support for the role of activated
calcineurin in inhibiting phagosome-lysosome fusion (Jaya-
chandran et al., 2007). Since these calcineurin inhibitors are
clinically used as immunosuppressive agents, it remains to be
established whether blocking this pathway will allow an inhibi-
tion of M. tuberculosis growth within infected individuals. How-
ever, these results do illustrate the importance of the coronin
1-dependent activation of calcineurin for the survival of M.
tuberculosis within macrophages (Figure 3) (Jayachandran
et al., 2007).
The Consequences of Macrophage Activation
and Its Subversion by M. tuberculosis
It is important to point out that the capacity ofM. tuberculosis to
block their transfer to lysosomes is operational almost exclu-
sively in nonactivated macrophages. Once macrophages have
become activated (which is the condition under which microbici-
dal activities are upregulated, usually following stimulation by
cytokines), M. tuberculosis is rapidly transferred to lysosomes
where they are destroyed by bactericidal activities such as the
generation of reactive oxygen and nitrogen, which are also upre-
gulated upon macrophages activation. Macrophage activation
can occur in response to several cytokines, of which inter-
feron-g and tumor necrosis factor alpha (TNF-a) are probably
the most important (Adams and Hamilton, 1984; Bogdan and
Schleicher, 2006; Flynn and Chan, 2001). Depressing the inter-
feron-g or TNF signaling pathways in either animal models or hu-
man hosts dramatically enhances the risk of developing tubercu-
losis, illustrating the importance of these cytokines (Jouanguy
et al., 1999; Stenger, 2005).
Figure 3. Model for the Activity of Coronin 1 in
Macrophages
Upon mycobacterial entry into macrophage phagosomes
mediated by macrophage receptors, coronin 1 (also
known as TACO) is recruited to the mycobacterial phago-
some. Coronin 1 retention leads to the activation of the
Ca2+-dependent phosphatase calcineurin, which is
responsible for blocking phagosome-lysosome fusion,
thereby allowing M. tuberculosis survival. The endoplas-
mic reticulum (ER) of the macrophage is shown as well.
Reprinted with permission from Pieters (2008a).
Generation of reactive oxygen and nitrogen
intermediates upon macrophage activation via
interferon-g is damaging to M. tuberculosis
(MacMicking et al., 1997b). Despite the high
toxicity of these reagents and their continuous
generation upon macrophage activation, M. tu-
berculosis can persist within this environment.
Mycobacterial resistance against reactive oxy-
gen and nitrogen intermediates is based on
multiple strategies that these bacilli have devel-
oped. First,mycobacteria produceKatG, a cata-
lase-peroxidase that can inactivate reactive
oxygen within phagosomes (Li et al., 1998). Second, subunits
of the mycobacterial proteasome are essential for coping with
nitric-oxide stress (Darwin et al., 2003). In eukaryotes, the pro-
teasome’s major function is to degrade proteins, while in pro-
karyotes its function is far less clear (Pearce et al., 2006). The
mycobacterial proteasomemay provide resistance against reac-
tive nitrogen intermediates, for example by functioning in the
elimination or refolding of proteins damaged by reactive nitrogen
intermediates (Darwin et al., 2003; Pieters and Ploegh, 2003).
The importance of nitric-oxide production in the control of tuber-
culosis is well established for mouse models (MacMicking et al.,
1997a). However, the situation in humans is less clear, and is
probably related to the difficulties in establishing systems to
study human macrophage functions in vitro (Nathan, 2006).
In addition, the diverse array of Toll-like receptor (TLR) ligands
(discussed in Review by Ishii et al., page 352 of this issue) can
also cause macrophage activation and thereby assist in the
control of tuberculosis (Merdzhitov and Janeway, 1998; Takeda
et al., 2003). Although the extent to which phagosome-lysosome
fusion depends on the precise type of ligand being internalized
via TLRs is not clear, regulation of phagosome maturation was
recently shown to occur through the TLR adaptor protein mye-
loid differentiation factor 88 (MyD88) and the mitogen-associ-
ated protein kinase (MAPK) p38 protein (Blander and Medzhitov,
2006). Accordingly, infection of mice lacking MyD88 with M.
tuberculosis results in rapid death of the host (Fremond et al.,
2004), highlighting the importance of the TLR pathway in the
control ofM. tuberculosis. Finally, recent studies in human mac-
rophages have linked the TLR pathway to a cascade upregulat-
ing the vitamin D receptor and vitamin D-1-hydroxylase genes.
This activation leads to the induction of cathelicidin, an antimi-
crobial peptide that effectively blocks M. tuberculosis prolifera-
tion (Figure 2) (Liu et al., 2006, 2007). Although earlier results
linking the vitamin D signaling pathway and resistance to tuber-
culosis were reported (Hill, 1998), exactly how this is achievedCell Host & Microbe 3, June 2008 ª2008 Elsevier Inc. 403
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ultraviolet (UV) light exposure, these findings explain the
observed benefits of sanatoria visits for tuberculosis patients
in high-altitude areas (Zasloff, 2006).
Mycobacterial glycolipids also play an important role in the
subversion of macrophage activation. The abundant cell-wall
component LAM as well as its glycosylated forms (manLAM)
can modulate signaling pathways that can be initiated to induce
macrophage activation, including interferon-g-mediated gene
expression, TLR activation, and phagosome-lysosome fusion
(Chan et al., 1991). In addition, LAM can block the activation of
an important kinase (MAPK) that is downstreamof various stimuli
that causemacrophage activation (Knutson et al., 1998). The fact
that a large part of theM. tuberculosis genome is devoted to the
production of molecules involved in lipid synthesis (Cole et al.,
1998) may be related to the many functions lipids play in the
survival of M. tuberculosis inside hosts.
In addition, modulation of bacterial metabolic pathways can
ensure a long-term survival within macrophages. For example,
when bacteria enter a nutrient-poor environment such as can oc-
cur within macrophage phagosomes, they become restricted to
fatty acids as their carbon source. This then activates the glyox-
ylate shunt pathway, which facilitates carbon retention through
de novo synthesis of carbohydrate (Honer zu Bentrup and Rus-
sell, 2001). The first step in this pathway is catalyzed by the en-
zyme isocitrate lyase. M. tuberculosis contains two genes that
encode for isocitrate lyase. A deletionmutant lacking both genes
is fully impaired in its intracellular replication and is rapidly elim-
inated from the lungs (Munoz-Elias and McKinney, 2005). This
suggests that the isocitrate lyase-based pathway is essential
for M. tuberculosis to be able to establish a persistent infection.
Several of the above-mentioned mechanisms require the
transfer of proteins into the host environment. The complexity
of themycobacterial cell wall poses constraints on protein secre-
tion, but pathogenicmycobacteria have evolved several systems
to deal with secretion. These include the generic Sec-dependent
secretion pathway to transport N-terminal signal sequence
containing proteins across the cytosolic membrane and a twin-
arginine transporter (Tat) system that is used to transport-folded
molecules across the membrane. A more recently described
secretion system is the early secretory antigenic target of 6 kD
(ESAT-6) system 1 (ESX-1) (Abdallah et al., 2007; DiGiuseppe
Champion and Cox, 2007), which is responsible for the secretion
of ESAT-6, CFP-10 (culture filtrate protein of 10 kD), and possibly
other molecules (Gao et al., 2004; McLaughlin et al., 2007). Inter-
estingly, both ESAT-6 and CFP-10 are important T cell antigenic
targets and essential for the virulence of M. tuberculosis (Gao
et al., 2004; Guinn et al., 2004; Hsu et al., 2003). Mycobacteria
encode five ESX-1-related secretion systems, named ESX 1–5,
that appear to have independent roles, some of which are essen-
tial for mycobacterial growth (Abdallah et al., 2007). How this
secretion system functions remains unknown. In addition, the
precise role in virulence of ESX secretion systems and the
substrates they secrete remains to be determined.
Apart from surviving within macrophage phagosomes, patho-
genic mycobacteria have also been suggested to escape into
the cytosol following phagocytosis in an ESX-1-dependent man-
ner (McDonough et al., 1993; van der Wel et al., 2007). Analysis
of cytosolic translocation within infected hosts may help to shed404 Cell Host & Microbe 3, June 2008 ª2008 Elsevier Inc.light on the importance of this phenomenon during an in vivo
infection (Jordao et al., 2008; Mwandumba et al., 2004).
From the above description, it seems thatM. tuberculosis has
evolved a strategy to counter virtually any bactericidal activity of
themacrophage. However, there are several host signaling path-
ways that, when activated, result in the destruction of M. tuber-
culosis, for which at present no clear subversion mechanisms
has been defined. One of these relies on the induction of the
immunity-related GTPase (IRG) members that are upregulated
following interferon-g treatment, promoting lysosomal delivery
(Feng et al., 2004; MacMicking et al., 2003, MacMicking, 2005;
Martens and Howard, 2006), possibly via the autophagosomal
pathway (Singh et al., 2006). However, genetic screens aimed
at analyzing the mode of M. tuberculosis interference with such
pathways may allow the definition of additional strategies used
by mycobacteria to counteract these host immune defense
mechanisms (Hisert et al., 2004).
Conclusions
The prolonged coevolution of M. tuberculosis with its human
hosts and specifically within macrophages has clearly resulted
in a number of survival strategies. These strategies range from
producing eukaryotic-like signaling molecules such as kinases
and phosphatases that interfere with host trafficking, the pro-
duction of modulators of macrophage activation, to the activa-
tion of eukaryotic Ca2+-dependent signaling molecules such as
calcineurin. Current efforts in understanding these virulence
strategies should not only allow the development of better strat-
egies to treat tuberculosis, but also contribute to unraveling the
cell biology of the host immune system.
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